Research ArticleCOAGULATION

Blockade of protease-activated receptor-4 (PAR4) provides robust antithrombotic activity with low bleeding

See allHide authors and affiliations

Science Translational Medicine  04 Jan 2017:
Vol. 9, Issue 371, eaaf5294
DOI: 10.1126/scitranslmed.aaf5294

Log in to view PDF

Log in through your institution

Log in through your institution